REFERENCES
- Wilcox CS. Diuretics. The Kidney 6th, BM Brenner. W. B. Saunders Company, Philadelphia, Pa 2000; 2219–2252
- Romano G, Favret G, Bartoli E. Micropuncture study of the effect of furosemide on proximal and distal tubules of the rat nephron. Renal Physiol and Biochem 1995; 18: 209–218
- Tenstad O, Williamson HE. Effect of furosemide on local and zonal glomerular filtration rate in the rat kidney. Acta Physiologica Scandinavica 1995; 155: 99–107
- Joppich R, Weyer P, Eife R. Effects of furosemide, captopril and indometacin on the renin-angiotensin system and the renal prostaglandins in anesthetized neonatal piglets. Arzneimittelforschung 1995; 45: 822–825
- Bak M, Shalmi M, Petersen JS, Poulsen LB, Christensen S. Effects of angiotensin-converting enzyme inhibition on renal adaptations to acute furosemide administration in conscious rats. J Pharmacol Exp Ther 1993; 266: 33–40
- Smith FG, Abraham J. Renal and renin responses to furosemide in conscious lambs during postnatal maturation. Can J Physiol Pharmacol 1995; 73: 107–112
- Scherzer P, Wald H, Popovtzer MM. Enhanced glomerular filtration and Na+-K+-ATPase with furosemide administration. Am J Physiol 1987; 252: F910–F915
- Knox FG, Wright FS, Howards SS, Berliner RW. Effect of furosemide on sodium reabsorption by proximal tubule of the dog. Am J Physiol 1969; 217: 192–198
- Burke TJ, Duchin KL. Glomerular filtration during furosemide diuresis in the dog. Kidney Int 1979; 16: 672–680
- Loon NR, Wilcox CS, Unwin RJ. Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int 1989; 36: 682–689
- Gottlieb SS, Skettino SL, Wolff A, Beckman E, Fisher ML, Freudenberger R, Gladwell T, Marshall J, Cines M, Bennett D, Liittschwager EB. Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure. J Am Coll Cardiol 2000; 35: 56–59
- ACC/AHA Task Force Report. Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Committee on evaluation and management of heart failure. J Am Coll Cardiol 1995; 26: 1376–1398
- Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31–41
- Russell CD, Bischoff PG, Kontzen FN, Rowell KL, Yester MV, Lloyd LK, Tauxe WN, Dubovsky EV. Measurement of glomerular filtration rate: single injection plasma clearance method without urine collection. J Nucl Med 1985; 26: 1243–1247
- Kasiske BL, Keane WF. Laboratory assessment of renal disease: Clearance, urinalysis, and renal biopsy. The Kidney 6th, BM Brenner. W. B. Saunders Company, Philadelphia, Pa 2000; 1129–1170
- Hansen GR. Diuretic drugs. Remington: The Science and Practice of Pharmacy19th. Mack Publishing Company, Easton, Pa 1995; 1039–1051
- Dikshit K, Vyden JK, Forrester JS, Chatterjee K, Prakash R, Swan HJC. Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N Engl J Med 1973; 288: 1087–1090
- Sica DA, Schoolwerth AC. Renal handling of organic anions and cations and renal excretion of uric acid. The Kidney 6th, BM Brenner. W. B. Saunders Company, Philadelphia, Pa 2000; 680–700
- van Olden RW, Guchelaar HJ, Struijik DG, Krediet RT, Arisz L. Acute effects of high-dose furosemide on residual renal function in CAPD patients. Perit Dial Int 2003; 23: 339–347
- Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, Dyer F, Gomez M, Bennett D, Ticho B, Beckman E, Abraham WT. BG9719 (CVT-124), an A1-adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 2002; 105: 1348–1353
- Goldsmith SR, Dick C. Differentiating systolic from diastolic heart failure: Pathophysiologic and therapeutic considerations. Am J Med 1993; 95: 645–655